Lung Cancer Europe shared on LinkedIn:
“People with lung cancer are excluded from clinical trials more than any other cancer group.
Our 2025 LuCE Clinical Trials Policy Briefing highlights how barriers like age, other health conditions, gender and genomic subtype are still keeping people out of research.
In many parts of Europe, access is getting worse. That needs to change.
More posts featuring Lung Cancer.